GSK’s recent deal to license out a rare liver disease drug just got sweeter.
GSK’s recent deal to license out a rare liver disease drug just got sweeter.
The FDA on Thursday approved linerixibat to treat cholestatic itch in …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Blenrep had been removed from sale after a trial failed to show it was superior to other treatments
FDA gives go-ahead to UK drugmaker’s multiple myeloma treatment Blenrep
Drug could provide a cure for condition that affects more than 250mn people
The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed access…
Deal comes as pharmaceutical groups rush to acquire smaller biotech firms with proven drug pipelines
Pierre Fabre claims to now be “aligned” with U.S. regulators on the path forward for a twice-rejected treatment. Elsewhere,…
